Back to all Thought Leadership

Senate Votes ‘Yes’ to Califf as Next FDA Commissioner

February 25, 2016

On Tuesday, February 23, the US Senate confirmed Robert Califf, MD to serve as the next FDA Commissioner. The position, held by Margaret Hamburg, MD for six years until she resigned in March 2015, was temporarily held by Stephen Ostroff, MD. Dr. Ostroff served as the Acting Commissioner for the ten month duration during which the final decision was being made regarding the appointment of the next Commissioner.

The Senate did not arrive at this decision without challenges; Califf, nominated by President Obama in September of last year, has received a lot of criticism. Ultimately, the objections were overcome although not unanimously; the final vote was 89-4.

For more information about Dr. Califf’s journey, view our previous FDA News articles:
Agency Alerts



Related Articles

FDA North America

February 25, 2016

Coronavirus (COVID-19) Update: FDA Approves First COVID-19 Treatment for Young Children

April 25, 2022 Today, the U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include pediatric patients 28 days of age and older weighing at...

Read More
Agency Alerts Regulatory Sciences

February 25, 2016

FDA Approves New Opioid Despite Controversy

On Friday, November 2nd, FDA announced its approval of Dsuvia™, a highly potent synthetic opioid manufactured by AcelRx Pharmaceuticals, Inc.  The drug is a sublingual (under the tongue) formulation...

Read More
Medical Device Agency Alerts

February 25, 2016

FDA Issues Draft Guidance to Advance Development of Combination Products

On Tuesday, February 5th, FDA published a draft guidance explaining the principles for premarket review of combination products, including how to determine which type of premarket submission is...

Read More